UK markets closed

Bone Biologics Corporation (BBLG)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.5200+0.0600 (+4.11%)
At close: 04:00PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Cost of revenue
0
-
0
0
0
0
Gross profit
0
-
0
0
0
0
Operating expenses
Research development
857.938
6,908
1,579
82.044
340.672
-
Selling general and administrative
1,977
2,520
2,086
1,021
484.342
-
Total operating expenses
2,835
9,428
3,665
1,103
825.014
-
Operating income or loss
-2,835
-9,428
-3,665
-1,103
-825.014
-
Interest expense
14.755
-
0
805.109
998.076
975.774
Total other income/expenses net
1,078
477.704
2,912
297.5
-
-
Income before tax
-2,553
-8,949
-1,485
-1,611
-1,823
-
Income tax expense
3.2
-
-
1.6
1.6
1.603
Income from continuing operations
-2,556
-8,949
-1,485
-1,611
-1,825
-
Net income
-2,556
-8,949
-1,485
-1,611
-1,825
-
Net income available to common shareholders
-2,556
-8,949
-1,485
-1,611
-1,825
-
Basic EPS
-13.52
-34.01
-31.15
-84.00
-151.20
-
Diluted EPS
-13.52
-34.01
-31.15
-84.00
-151.20
-
Basic average shares
163.6
263.137
47.658
18.924
12.13
-
Diluted average shares
163.6
263.137
47.658
18.924
12.13
-